Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System
Digital Health Global
MARCH 27, 2023
(NYSE and TASE: TEVA), today announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been implemented within California’s Desert Oasis Healthcare (DOHC) system. More than 34 million Americans live with a chronic lung disease, and approximately 25 million people in the U.S. currently have asthma.
Let's personalize your content